| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |